Low to Moderate Dose Anthracycline-Based Chemotherapy Is Associated With Early Noninvasive Imaging Evidence of Subclinical Cardiovascular Disease-Reference-Cited by-同舟云学术

Low to Moderate Dose Anthracycline-Based Chemotherapy Is Associated With Early Noninvasive Imaging Evidence of Subclinical Cardiovascular Disease

Published:2013-08 Issue:8 Volume:6 Page:877-885
ISSN:1936-878X
Container-title:JACC: Cardiovascular Imaging
language:en
Short-container-title:JACC: Cardiovascular Imaging

Author:

Drafts Brandon C.,Twomley Katie M.,D'Agostino Ralph,Lawrence Julia,Avis Nancy,Ellis Leslie R.,Thohan Vinay,Jordan Jennifer,Melin Susan A.,Torti Frank M.,Little William C.,Hamilton Craig A.,Hundley W. Gregory

Funder

National Institutes of Health

Susan G. Komen Foundation

National Institutes of Health, Siemens, Bracco, and Prova

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Reference32 articles.

1. Competing causes of death for women with breast cancer and change over time from 1975 to 2003;Du;Am J Clin Oncol,2008

2. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer;Hooning;J Natl Cancer Inst,2007

3. Myocardial infarction mortality risk after treatment for Hodgkin’s disease: a collaborative British cohort study;Swerdlow;J Natl Cancer Inst,2007

4. Doxorubicin-induced cardiomyopathy;Singal;N Engl J Med,1998

5. Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology;Eschenhagen;Eur J Heart Fail,2011

Cited by 323 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular imaging in cardio-oncology;Japanese Journal of Radiology;2024-08-29

2. Cancer Therapy and Exercise Intolerance: The Heart Is But a Part;JACC: CardioOncology;2024-08

3. The impact of non- and anthracycline-based chemotherapy on fatigue in breast cancer survivors: results from WF-97415;Supportive Care in Cancer;2024-07-19

4. EGFR-TKIs - induced cardiotoxicity in NSCLC: incidence, evaluation, and monitoring;Frontiers in Oncology;2024-06-24

5. Cardiac Dysfunction Among Breast Cancer Survivors: Role of Cardiotoxic Therapy and Cardiovascular Risk Factors;Journal of Clinical Oncology;2024-06-04